PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech

PLI schemes should also focus on entities supporting production of branded pharma products: Bharat Biotech Currently, the government through the Department of Pharmaceuticals (DoP) is currently implementing three PLI schemes -- Bulk Drugs (Rs 6,940 crore), Medical Devices (Rs 3,420 crore) and Pharmaceuticals (Rs 15,000 crore) -- to promote manufacturing activity. Prasad noted that the domestic pharma sector should "focus upon innovation." https://ift.tt/ZInpjJX